相似文献
1
Transcatheter Closure of an Atrial Septal Defect.
Intern Med. 2022 Jan 1;61(1):1-2. doi: 10.2169/internalmedicine.6946-20. Epub 2021 Feb 15.
2
Transcatheter closure of an atrial septal defect with high risk of erosion using a Figulla Flex II atrial septal defect occluder.
Cardiovasc Interv Ther. 2017 Oct;32(4):436-439. doi: 10.1007/s12928-017-0457-x. Epub 2017 Jan 20.
3
Cobrahead Deformity in the Right Atrial Disc of a New-Generation Occlutech Figulla Flex II Atrial Septal Defect Occluder Device.
Tex Heart Inst J. 2015 Oct 1;42(5):454-7. doi: 10.14503/THIJ-14-4179. eCollection 2015 Oct.
4
Efficacy and safety of atrial septal defect closure using Occlutech Figulla Flex II compared with Amplatzer Septal Occluder.
Heart Vessels. 2021 May;36(5):704-709. doi: 10.1007/s00380-020-01739-1. Epub 2021 Jan 2.
5
Malposition of left atrial disc and feasibility of recapturing Figulla-II Occlutech septal occluder.
Cardiol Young. 2020 Mar;30(3):444-445. doi: 10.1017/S104795112000027X. Epub 2020 Feb 18.
6
Lipomatous Atrial Septal Hypertrophy and Atrial Septal Defect With Rim Deficiency.
JACC Cardiovasc Interv. 2022 Feb 14;15(3):e31-e33. doi: 10.1016/j.jcin.2021.09.040. Epub 2021 Nov 24.
7
Comparing the Performance of Amplatzer® and Occlutech® Figulla® Septal Occluders: The Pediatric Point of View. A Retrospective Study.
Isr Med Assoc J. 2017 Sep;19(9):557-561.
8
Appropriate device selection for transcatheter atrial septal defect closure using three-dimensional transesophageal echocardiography.
Int J Cardiovasc Imaging. 2021 Apr;37(4):1159-1168. doi: 10.1007/s10554-020-02095-x. Epub 2020 Nov 5.
9
Comparison of the Occlutech ® Figulla ® septal occluder and Amplatzer ® septal occluder for atrial septal defect device closure.
Pediatr Cardiol. 2015 Jun;36(5):935-41. doi: 10.1007/s00246-015-1103-y. Epub 2015 Jan 30.
10
Safety of Occlutech Septal Occluder ACCELL Flex II for Transcatheter Closure of Secundum Atrial Septal Defects in Children: A Long-Term Follow-Up.
J Interv Cardiol. 2022 Jan 4;2022:8886813. doi: 10.1155/2022/8886813. eCollection 2022.
引用本文的文献
1
Efficacy and Safety of Percutaneous ASD Closure in Adults: Comparative Outcomes of Occluder Devices in a Single-Center Cohort.
J Clin Med. 2025 Mar 10;14(6):1867. doi: 10.3390/jcm14061867.
2
Cardiac troponin I release after transcatheter closure of atrial septal defects is associated with supraventricular arrhythmias on early follow-up.
Postepy Kardiol Interwencyjnej. 2024 Sep;20(3):338-344. doi: 10.5114/aic.2024.142326. Epub 2024 Aug 14.
3
Echocardiography in Simple Congenital Heart Diseases: Guiding Adult Patient Management.
J Cardiovasc Echogr. 2023 Oct-Dec;33(4):171-182. doi: 10.4103/jcecho.jcecho_52_23. Epub 2024 Feb 26.
本文引用的文献
1
Practical Therapeutic Management of Percutaneous Atrial Septal Defect Closure.
Intern Med. 2022 Jan 1;61(1):15-22. doi: 10.2169/internalmedicine.5944-20. Epub 2021 Feb 15.
2
Cardiac Erosions After Transcatheter Atrial Septal Defect Closure With the Occlutech Figulla Flex Device.
JACC Cardiovasc Interv. 2019 Jul 22;12(14):1397-1399. doi: 10.1016/j.jcin.2019.03.005.
3
Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database.
J Thorac Cardiovasc Surg. 2009 Jun;137(6):1334-41. doi: 10.1016/j.jtcvs.2009.02.032.
4
The influence of morphological changes in amplatzer device on the atrial and aortic walls following transcatheter closure of atrial septal defects.
J Interv Cardiol. 2009 Feb;22(1):83-91. doi: 10.1111/j.1540-8183.2008.00421.x.
5
Device closure of large atrial septal defects: technical considerations.
J Cardiovasc Med (Hagerstown). 2007 Jan;8(1):30-3. doi: 10.2459/01.JCM.0000247432.74699.47.
6
Use of a straight, side-hole delivery sheath for improved delivery of Amplatzer ASD occluder.
Catheter Cardiovasc Interv. 2007 Jan;69(1):15-20. doi: 10.1002/ccd.20953.
Zotero 插件